HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

T22 peptide

CXCR4 antagonist; amino acid sequence in first source

Also Known As:

NH2-RRWCYRKCYKGYCYRKCR-COOH

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - T22 peptide: 3

Experts

1.	Alba-Castellón, Lorena: 1 article (02/2022)
2.	Arroyo-Solera, Irene: 1 article (02/2022)
3.	Casanova, Isolda: 1 article (02/2022)
4.	Gallardo, Alberto: 1 article (02/2022)
5.	León, Xavier: 1 article (02/2022)
6.	Mangues, Ramon: 1 article (02/2022)
7.	Quer, Miquel: 1 article (02/2022)
8.	Rioja-Blanco, Elisa: 1 article (02/2022)
9.	Serna, Naroa: 1 article (02/2022)
10.	Sánchez-García, Laura: 1 article (02/2022)

Related Diseases

1.	Neoplasm Metastasis (Metastasis) 08/10/2010 - "Long-term treatment with T22 peptide (a CXCR4/SDF-1 inhibitor) and YY1 silencing can reduce in vivo systemic neoangiogenesis (P < 0.01 and P < 0.05 vs. control, respectively) during metastasis. "
2.	Melanoma (Melanoma, Malignant) 03/14/2023 - "Here, we prove that the CXCR4 antagonist T22 peptide specially targeted and became internalized into CXCR4+ melanoma cells. "
3.	Squamous Cell Carcinoma of Head and Neck 02/04/2022 - "Both nanotoxins contain the T22 peptide ligand to specifically target CXCR4-overexpressing HNSCC cells. "

Related Drugs and Biologics

1.	Ligands